US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
ドイツ
TG
Social Chain AG (PU11) 銘柄情報

Social Chain AG (PU11)

0.007

-0.0025

( -26.32% )

更新日時： 14:30:17

Social Chain AG (PU11) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.007

( -26.32% )

買値

0.0055

売値

0.0135

出来高

1,000

0.007 日の範囲 0.007

0.002 52 週間の範囲 0.029

時価総額

前日終値

0.0095

始値

0.007

時刻

最終取引時間

14:30:17

財務取引量

-

VWAP

-

平均取引量 (3 か月)

1,475 €

発行済株式数

18,370,000

配当利回り

PER

-0

1 株当たり利益 (EPS)

-13.86

歳入

276.35M

純利益

-216.03M

The Social Chain AG, a brand and product company, provides social media marketing services. The company offers product development, brand building, and selling, as well as legal testing, production, quality assurance, marketing, communication, and logistics services for various brands and products. ... The Social Chain AG, a brand and product company, provides social media marketing services. The company offers product development, brand building, and selling, as well as legal testing, production, quality assurance, marketing, communication, and logistics services for various brands and products. It operates in Germany, the United States, Austria, Switzerland, the United Kingdom, the Netherlands, Romania, Spain, Belgium, Italy, France, the Czech Republic, Sweden, other European countries, Asia, and the Americas. The Social Chain AG was incorporated in 2004 and is headquartered in Berlin, Germany. 詳細を表示

セクター

Media

業界

Interactive Multi-media

ウェブサイト

www.socialchain.de

本社

Berlin, Germany

設立

2026

Social Chain AG is listed in the Media sector of the Tradegate (DE) with ticker PU11. The last closing price for Social Chain was 0.01 €. Over the last year, Social Chain shares have traded in a share price range of 0.002 € to 0.029 €.

Social Chain currently has 18,370,000 shares in issue. The market capitalisation of Social Chain is 128,590.00 € . Social Chain has a price to earnings ratio (PE ratio) of -0.00.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.0015	27.2727272727	0.0055	0.011	0.0055	263	0.00968569	DE
4	0.0025001	55.5590124225	0.0044999	0.011	0.0044999	4268	0.00701402	DE
12	-0.0019999	-22.2213580151	0.0089999	0.0205	0.0035	14391	0.01168499	DE
26	0.0015	27.2727272727	0.0055	0.029	0.002	18814	0.01508794	DE
52	-0.009	-56.25	0.016	0.029	0.002	16168	0.01272825	DE
156	-2.643	-99.7358490566	2.65	2.78	0.002	43530	0.20649871	DE
260	-33.593	-99.9791666667	33.6	58	0.002	30617	3.79078978	DE

PU11 - Frequently Asked Questions (FAQ)

What is the current Social Chain AG share price?

The current share price of Social Chain AG is 0.007 €

How many Social Chain AG shares are in issue?

Social Chain AG has 18,370,000 shares in issue

What is the market cap of Social Chain AG?

The market capitalisation of Social Chain AG is EUR 128.59k

What is the 1 year trading range for Social Chain AG share price?

Social Chain AG has traded in the range of 0.002 € to 0.029 € during the past year

What is the PE ratio of Social Chain AG?

The price to earnings ratio of Social Chain AG is -0

What is the cash to sales ratio of Social Chain AG?

The cash to sales ratio of Social Chain AG is 0

What is the registered address of Social Chain AG?

The registered address for Social Chain AG is Alte Jakobstrasse 85/86, Berlin, Berlin, 10179

What is the Social Chain AG website address?

The website address for Social Chain AG is www.socialchain.de

Which industry sector does Social Chain AG operate in?

Social Chain AG operates in the Interactive Multi-Media sector

Methinks

Methinks 7分前

https://www.hampshirechronicle.co.uk/news/26185479.university-winchester-wins-cyber-security-funding/
I'll teach them a thing or two - W.A.V.E.

Methinks

Methinks 9分前

https://www.universiteitleiden.nl/en/news/2026/06/how-do-you-prepare-for-the-threats-of-tomorrow
Easy - ACT NOW WITH WAVE.

SDCRBS

Sagacious = “Showing unusually good judgment before everyone else sees it.”
It’s not just “smart.”
It’s smart at the right time, before the crowd, based on insight rather than hype.

When investors call a move sagacious, they mean:

You recognized the under

Methinks

Methinks 10分前

https://cybersecuritynews.com/optinmonster-plugin-exposes-wordpress-sites/
ACT NOW WITH WAVE.

Investor2014

Investor2014 14分前

One must be a believer around here, as reflected by the emojis. To some an idea is more important than fact.

RuudSaltis

RuudSaltis 20分前

The shell announcement wasn’t falling out of heaven. Everything has a reason. As told earlier this announcement wil trigger new serious investors!

10thMountain

10thMountain 20分前

EMBR…YEP! This is the calm before the storm. Here’s a company post.TWO definitive agreements signed and more updates coming….

https://x.com/embarrdownsinc/status/2065463502832382124?s=46

10thMountain

10thMountain 20分前

EMBR…YEP! This is the calm before the storm. Here’s a company post.TWO definitive agreements signed and more updates coming….

https://x.com/embarrdownsinc/status/2065463502832382124?s=46

muee88

muee88 29分前

“Our corporate headquarters are located at 4800 Montgomery Lane, Bethesda, Maryland, where we lease and occupy an aggregate of approximately 7,097 square feet of office space. The lease covering this property is currently scheduled to expire in August 2026.”

Well the property marketin

eagle8

eagle8 32分前

https://www.gov.uk/government/news/unique-liaison-programme-set-to-reinforce-close-collaboration-between-mhra-and-fda?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=95982d69-cc79-409a-a44a-cac5e2e70ff4&utm_content=immediately

US Market News

US Market News 33分前

KBR Launches Inaugural Innovation Studio Powered by Applied Computing in BengaluruJune 16, 2026 3:35 AM
PR Newswire (US) class="legendSpanClass"BENGALURU, India, class="legendSpanClass"June 16, 2026 /PRNewswire/ -- KBR (NYSE: KBR) launch

tkg

I don't see any end in sight for the insatiable demand for compute and data centers, to the contrary, demand is going parabolic.

Qualcomm CEO says AI agents will replace apps — as chip giant works on 40 new AI-powered devices
PUBLISHED TUE, JUN 16 20261:08 AM EDT

knrorrel

knrorrel 35分前

GPUS Everyone should keep an eye on this one; GPUS should continue to rise over the coming days and weeks. And once a deal is announced, the stock’s real future should truly take off—driven by strong revenue and massive profits. imho ,🚀 https://investorshub.advfn.com/boards/read_msg.aspx?me

silattore

silattore 35分前

WOW! Umpteenth dilution. Another umpteenth times to go. Well done.
Didn't know being a CEO and managing a company is this easy, as far as AMC is concerned. You earn money or lose money, doesn't matter. There is always dilution.

If retail shareholders oppose another dilution, t

knrorrel

knrorrel 36分前

GPUS
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177706706

knrorrel

knrorrel 36分前

GPUS Everyone should keep an eye on this one; GPUS should continue to rise over the coming days and weeks. And once a deal is announced, the stock’s real future should truly take off—driven by strong revenue and massive profits. imho ,🚀 https://investorshub.advfn.com/boards/read_msg.aspx?me

CelestialSage6

CelestialSage6 47分前

Yes, I understand. Even if you combine all of that, can it beat Dupixent? Alteogen only collaborates with the best companies. On the other hand, Halozyme has signed contracts with companies that I don't even know if they are actually working with. So, it's not Alteogen signing with junk, but Halozym

CA Market News

CA Market News 48分前

Herbal Dispatch Provides Update on Domestic Retail Operations and Proprietary Brand ExpansionJune 16, 2026 3:01 AM
NewsfileVancouver, B

tkg

The Strategic Verdict

This Forbes article is a massive structural validation for long-term Lightwave shareholders. For years, the bears argued that Lightwave was a standalone science project trying to force its way into the market.

Now, the U.S. government and GlobalFou

Hellie

Hellie 56分前

11/06 , maybe you're right!

biotechinvestor1

biotechinvestor1 58分前

Here are a few of those drugs:
Ebglyss (IL-13)Adbry (IL-13)Nemluvio (IL-31 receptor)Late-stage agents such as zumilokibart.

Henk van vleuten

Henk van vleuten 60分前

When was it publiced? Maybe this why on 12june there was a huge spike on Jan 2027 15 options??

biotechinvestor1

biotechinvestor1 1時間前

You ate wrong again! Not all Halozyme targets are public info for obvious competitive reasons.
There are number of other drugs in the class of Dupixent that halozyme might have an exclusive non-disclosed contract for. Here are a few of those drugs:

Amundi MSCI EM Asia ESG ...

iShares MSCI Malaysia

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。